These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 13876658)

  • 1. In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine.
    CARLSSON A; LINDQVIST M
    Acta Physiol Scand; 1962 Jan; 54():87-94. PubMed ID: 13876658
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of alpha-methyl-DOPA and alpha-methyl-metatyrosine on the metabolism of norepinephrine and serotonin in vivo.
    HESS SM; CONNAMACHER RH; OZAKI M; UDENFRIEND S
    J Pharmacol Exp Ther; 1961 Nov; 134():129-38. PubMed ID: 13907002
    [No Abstract]   [Full Text] [Related]  

  • 3. Decarboxylation-dependent transamination catalyzed by mammalian 3,4-dihydroxyphenylalanine decarboxylase.
    O'Leary MH; Baughn RL
    J Biol Chem; 1977 Oct; 252(20):7168-73. PubMed ID: 561784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of noradrenaline and 5-hydroxytryptamine disappearance induced by alpha-methyl-dopa and alpha-methyl-metatyrosine.
    Andén NE; Fuxe K; Henning M
    Eur J Pharmacol; 1969 Dec; 8(3):302-9. PubMed ID: 5263681
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of alpha-methyl-3,4-dihydroxyphenylalanine (methyldopa), reserpine and related agents on some vascular responses in the dog.
    STONE CA; ROSS CA; WENGER HC; LUDDEN CT; BLESSING JA; TOTARO JA; PORTER CC
    J Pharmacol Exp Ther; 1962 Apr; 136():80-8. PubMed ID: 13917453
    [No Abstract]   [Full Text] [Related]  

  • 6. ON THE MECHANISM OF NORADRENALINE DEPLETION BY ALPHA-METHYL METATYROSINE AND METARAMINOL.
    ANDEN NE
    Acta Pharmacol Toxicol (Copenh); 1964; 21():260-71. PubMed ID: 14209617
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha methyl dopa in the treatment of hypertension.
    DOYLE A; TREVAKS G
    Med J Aust; 1962 Jul; 49(2)():55-6. PubMed ID: 13887654
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of alpha-methyl-dopa for the treatment of chronic hypertension].
    ARNOLD OH
    Dtsch Med Wochenschr; 1962 Apr; 87():844-8. PubMed ID: 13862447
    [No Abstract]   [Full Text] [Related]  

  • 9. Febrile reactions to L-alpha-methyl-dopa. Report of three cases.
    LEONARD JW; GIFFORD RW; HUMPHREY DC
    Cleve Clin Q; 1962 Jul; 29():144-7. PubMed ID: 14464072
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension.
    GILLESPIE L; OATES JA; CROUT JR; SJOERDSMA A
    Circulation; 1962 Feb; 25():281-91. PubMed ID: 13898638
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of serotonin formation by alpha-methyl-DOPA].
    WESTERMANN E; BALZER H; KNELL J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1958; 234(3):194-205. PubMed ID: 13600388
    [No Abstract]   [Full Text] [Related]  

  • 12. [alpha-Methyl-DOPA. Therapeutic experiences in hypertension and biochemical research on its mode of action].
    SCHAUB F; NAGER F; SCHAER H; ZIEGLER W; LICHTLEN P
    Schweiz Med Wochenschr; 1962 May; 92():620-8. PubMed ID: 14498080
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary report on the clinical effectiveness of 1-alpha-methyl-DOPA (Aldomet) in the treatment of hypertension].
    FELLINGER K; GRABNER G; KRYGICZ H
    Wien Z Inn Med; 1961 Dec; 42():527-30. PubMed ID: 13892223
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of alpha-methyl DOPA in severe and malignant hypertension.
    CANNON PJ; WHITLOCK RT; MORRIS RC; ANGERS M; LARAGH JH
    JAMA; 1962 Mar; 179():673-81. PubMed ID: 13876240
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trial of alpha-methyl-dopa in a case of carcinoidosis].
    GEFFROY Y; CARTIER P; LEMOINE P; FABLET J; MOREAU J; MALANDRIN C; LEGRAND M
    Pathol Biol; 1962 Jan; 10():75-7. PubMed ID: 13897491
    [No Abstract]   [Full Text] [Related]  

  • 16. Antagonism between L-alpha-methyl DOPA and reserpine.
    NECINA J
    Life Sci (1962); 1962 Jul; 1():301-3. PubMed ID: 14478718
    [No Abstract]   [Full Text] [Related]  

  • 17. 5-Hydroxytryptamine levels in brain of mice pretreated with Alpha-methyl-dopa.
    LEROY JG
    Arch Int Pharmacodyn Ther; 1961 Dec; 134():492-6. PubMed ID: 14464270
    [No Abstract]   [Full Text] [Related]  

  • 18. Agranulocytosis caused by methyl dopa (Aldomet).
    HALLWRIGHT GP
    N Z Med J; 1961 Dec; 60():567-70. PubMed ID: 13903962
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin synthesis in carcinoid patients. Its inhibition by alpha-methyl-dopa, with measurement of associated increases in urinary 5-hydroxytryptophan.
    SJOERDSMA A; OATES JA; ZALTZMAN P; UDENFRIEND S
    N Engl J Med; 1960 Sep; 263():585-8. PubMed ID: 13831424
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methyl-dopa (Aldomet), a new principle in the treatment of high blood pressure].
    MATHISEN HS
    Tidsskr Nor Laegeforen; 1962 Mar; 82():353-5. PubMed ID: 14471146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.